Market Overview:
The global human parainfluenza viruses diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of HPV infections, rising demand for early diagnosis and treatment of HPV-related diseases, and technological advancements in HPV diagnostics. The global human parainfluenza viruses diagnostics market is segmented by type, application, and region. By type, the market is divided into HPV testing, follow-up HPV testing, and co-testing. By application, the market is segmented into cervical cancer screening, vaginal cancer screening,, and other applications. The cervical cancer screening segment accounted for the largest share of the global human parainfluenza viruses diagnostics market in 2017 owing to high prevalence of cervical cancer worldwide. Geographically, the global human parainfluenza viruses diagnosticsmarketis divided into North America,, Latin America,, Europe,, Asia Pacific,,and Middle East & Africa,. In 2017,.
Product Definition:
Human parainfluenza viruses (HPIVs) are a group of four closely related viruses that cause respiratory infections in humans. These viruses are highly contagious and can be spread through coughing and sneezing. HPIV infections can range from mild cold-like symptoms to more serious illnesses such as bronchitis, pneumonia, or even death. The importance of human parainfluenza virus diagnostics is to help identify the specific virus causing an infection so the most appropriate treatment can be prescribed.
HPV Testing:
Human Papillomavirus (HPV) Testing is a procedure to detect the presence of HPVs in a sample taken from patient’s skin. There are more than 100 strains of HPV, out of which 13 are high risk or cancerous and can lead to cervical cancer in women.
Follow-up HPV Testing:
Follow-up HPV testing is a process of repeated screening for Human Papillomavirus (HPV) infections to identify patients who have recovered from the initial infection but are at risk of developing another one. It also helps in monitoring the treatment regime to prevent recurrence.
The first step in follow-up HPV testing is sample collection that includes urine or swabbing the skin, usually within 24 hours after exposure to an infected person or their excreta,.
Application Insights:
Cervical cancer screening dominated the global human parainfluenza viruses diagnostics market in 2017. This is attributed to the growing prevalence of high-risk types, such as HPVs 16 and 18, which are associated with almost all cases of cervical cancer. Moreover, a rise in women's participation in sports and other physical activities increases their risk of developing this disease. As a result, demand for human parainfluenza virus (HPV) tests has increased significantly over the past few years to screen women before they develop symptoms or become pregnant.
The other segment is expected to exhibit lucrative growth during the forecast period due to an increase in number of people diagnosed with colds each year despite advanced healthcare facilities and medicines available today worldwide.
Regional Analysis:
North America dominated the global human parainfluenza viruses diagnostics market in 2017. This is due to the presence of a large number of players, high adoption rate for new technologies, and increasing government initiatives. For instance, in 2016, Merck & Co., Inc. launched two new tests under its brand name ‘COVID-19 Test’ and ‘HPV Test’ which can be used for both HPV DNA testing as well as follow-up testing for any abnormal result. These tests are now available at most healthcare centers throughout U.S.
Asia Pacific region is expected to grow at a lucrative rate during the forecast period owing to an increase in government spending on health care facilities along with rising awareness about cancer screening programs among women population especially from countries like India China Japan Thailand Philippines Indonesia South Korea etc.
Growth Factors:
- Increasing incidence of human parainfluenza viruses (HPIVs) infections: The global incidence of HPIVs is increasing due to the increase in international travel and changing demographics. This is expected to drive the demand for HPIV diagnostics.
- Growing awareness about HPIVs: There is growing awareness among healthcare professionals and patients about the symptoms, diagnosis, and treatment of HPIV infections. This is expected to boost the demand for HPIV diagnostics.
- Technological advancements in diagnostic tests: There has been a significant advancement in diagnostic technologies for detecting HPVIs over the past few years. This is likely to spur growth in the market for HPVI diagnostics over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Parainfluenza Viruses Diagnostics Market Research Report
By Type
HPV Testing, Follow-up HPV Testing, Co-testing
By Application
Cervical Cancer Screening, Vaginal Cancer Screening, Other
By Companies
Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Human Parainfluenza Viruses Diagnostics Market Report Segments:
The global Human Parainfluenza Viruses Diagnostics market is segmented on the basis of:
Types
HPV Testing, Follow-up HPV Testing, Co-testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cervical Cancer Screening, Vaginal Cancer Screening, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qiagen
- Roche Diagnostics
- Hologic
- Abbott Laboratories
- BD
- Seegene
Highlights of The Human Parainfluenza Viruses Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HPV Testing
- Follow-up HPV Testing
- Co-testing
- By Application:
- Cervical Cancer Screening
- Vaginal Cancer Screening
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Parainfluenza Viruses Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human parainfluenza viruses are a family of viruses that cause respiratory illness in humans. There are four human parainfluenza virus types: H1N1, H3N2, H5N1, and SARS-CoV-2. Parainfluenza diagnostics tests detect the presence of these viruses in samples from people who have respiratory illness.
Some of the major companies in the human parainfluenza viruses diagnostics market are Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene.
The human parainfluenza viruses diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Parainfluenza Viruses Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Parainfluenza Viruses Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Parainfluenza Viruses Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Parainfluenza Viruses Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Parainfluenza Viruses Diagnostics Market Size & Forecast, 2020-2028
4.5.1 Human Parainfluenza Viruses Diagnostics Market Size and Y-o-Y Growth
4.5.2 Human Parainfluenza Viruses Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 HPV Testing
5.2.2 Follow-up HPV Testing
5.2.3 Co-testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cervical Cancer Screening
6.2.2 Vaginal Cancer Screening
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Parainfluenza Viruses Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Parainfluenza Viruses Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 HPV Testing
9.6.2 Follow-up HPV Testing
9.6.3 Co-testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cervical Cancer Screening
9.10.2 Vaginal Cancer Screening
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 HPV Testing
10.6.2 Follow-up HPV Testing
10.6.3 Co-testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cervical Cancer Screening
10.10.2 Vaginal Cancer Screening
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 HPV Testing
11.6.2 Follow-up HPV Testing
11.6.3 Co-testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cervical Cancer Screening
11.10.2 Vaginal Cancer Screening
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 HPV Testing
12.6.2 Follow-up HPV Testing
12.6.3 Co-testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cervical Cancer Screening
12.10.2 Vaginal Cancer Screening
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 HPV Testing
13.6.2 Follow-up HPV Testing
13.6.3 Co-testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cervical Cancer Screening
13.10.2 Vaginal Cancer Screening
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Parainfluenza Viruses Diagnostics Market: Competitive Dashboard
14.2 Global Human Parainfluenza Viruses Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Qiagen
14.3.2 Roche Diagnostics
14.3.3 Hologic
14.3.4 Abbott Laboratories
14.3.5 BD
14.3.6 Seegene
